43 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
of operations may be harmed. Furthermore, the combined company will not have long-term arrangements with many of its significant suppliers. If the combined … and evaluation of its long-term prospects and strategies, the Apexigen Board frequently reviews, with Apexigen’s management, strategic and financial
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:03pm
, in addition to proceeds of $2.8 million from the private placement received in January 2023 (see Note 14), and to pursue our long-term development strategy. We … are delivered or the services are performed. We evaluate such payments for current or long-term classification based on when they will be realized.
Stock-based
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:02pm
(see Note 14), and to pursue our long-term development strategy. We may seek additional funding through the issuance of common stock, other equity … available clinical data or literature, and plans for clinical trials, among other things, to the FDA as part of an IND. Some long-term preclinical
POS AM
ion6inuugcoedn
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
n7pgahx4bke5t7dm876d
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
z5qn6a89i7q2y
9 Sep 22
Prospectus supplement
4:40pm
424B3
yjfi96jxpdg
9 Sep 22
Prospectus supplement
4:38pm
8-K/A
EX-99.2
r70wiog vn3sixvn5n
18 Aug 22
Index to Unaudited Condensed Financial Statements
4:48pm
8-K/A
EX-99.1
s39q23ogkzm 7977ceir
18 Aug 22
Index to Unaudited Condensed Financial Statements
4:48pm
424B3
38afbigkc3j guixf
6 Jul 22
Prospectus supplement
4:18pm
425
d8wum vvoe
29 Jun 22
Business combination disclosure
4:39pm